197 related articles for article (PubMed ID: 12784553)
1. [Eradication of BHV-1 in cattle herds in Saxony-Anhalts using a vaccine lacking a marker--report of an experience].
Gehrmann B; Tyrpe A; Körber R
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):203-7. PubMed ID: 12784553
[TBL] [Abstract][Full Text] [Related]
2. [Conventional and marked BHV-1 vaccines in Germany: a brief review].
Trapp S; König P; Beer M
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):208-15. PubMed ID: 12784554
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic markers in the prevention of bovine herpesvirus type 1: possibilities and limitations].
Beer M; König P; Schielke G; Trapp S
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):183-91. PubMed ID: 12784550
[TBL] [Abstract][Full Text] [Related]
5. [BHV-1 eradication program in Bavaria: a marker-independent strategy].
Truyen U; Isa G; Gerbermann H; Bogner KH; Banzhaf K; Köstler M; Pauels FJ; Czerny CP; Wittkowski G
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):197-202. PubMed ID: 12784552
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the performance to date of the BHV-1 eradication campaign in Saxony-Anhalt (Germany)].
Denzin N; Gehrmann B; Tyrpe A; Ewert B
Berl Munch Tierarztl Wochenschr; 2004; 117(9-10):353-9. PubMed ID: 15495925
[TBL] [Abstract][Full Text] [Related]
7. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.
Muylkens B; Meurens F; Schynts F; de Fays K; Pourchet A; Thiry J; Vanderplasschen A; Antoine N; Thiry E
Vet Microbiol; 2006 Mar; 113(3-4):283-91. PubMed ID: 16321480
[TBL] [Abstract][Full Text] [Related]
8. Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field.
Dispas M; Schynts F; Lemaire M; Letellier C; Vanopdenbosch E; Thiry E; Kerkhofs P
Vet Rec; 2003 Aug; 153(7):209-12. PubMed ID: 12956298
[TBL] [Abstract][Full Text] [Related]
9. Partial protection induced by a BHV-1 recombinant vaccine against challenge with BHV-5.
Spilki FR; Silva AD; Hübner S; Esteves PA; Franco AC; Driemeier D; Roehe PM
Ann N Y Acad Sci; 2004 Oct; 1026():247-50. PubMed ID: 15604501
[TBL] [Abstract][Full Text] [Related]
10. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant.
Chowdhury SI; Ross CS; Lee BJ; Hall V; Chu HJ
Am J Vet Res; 1999 Feb; 60(2):227-32. PubMed ID: 10048557
[TBL] [Abstract][Full Text] [Related]
12. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
Makoschey B; Beer M
Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves.
Salt JS; Thevasagayam SJ; Wiseman A; Peters AR
Vet J; 2007 Nov; 174(3):616-26. PubMed ID: 17276108
[TBL] [Abstract][Full Text] [Related]
14. [Spread of an intramuscularly administered live gE-negative BHV1 marker vaccine in 2 cattle farms].
van der Poel WH; Hage JJ
Tijdschr Diergeneeskd; 1998 Feb; 123(4):109-11. PubMed ID: 9537086
[TBL] [Abstract][Full Text] [Related]
15. Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine.
Castrucci G; Ferrari M; Marchini C; Salvatori D; Provinciali M; Tosini A; Petrini S; Sardonini Q; Lo Dico M; Frigeri F; Amici A
Comp Immunol Microbiol Infect Dis; 2004 May; 27(3):171-9. PubMed ID: 15001312
[TBL] [Abstract][Full Text] [Related]
16. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
Kalthoff D; König P; Trapp S; Beer M
Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
[TBL] [Abstract][Full Text] [Related]
17. [Requirements for the use of ELISA systems in eradication programs].
Bogner KH
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):259-62. PubMed ID: 12784562
[TBL] [Abstract][Full Text] [Related]
18. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
[TBL] [Abstract][Full Text] [Related]
19. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1.
van Drunen Littel-van den Hurk S
Vet Microbiol; 2006 Mar; 113(3-4):275-82. PubMed ID: 16330163
[TBL] [Abstract][Full Text] [Related]
20. Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus.
Toussaint JF; Rziha HJ; Bauer B; Letellier C; Kerkhofs P
Vet Rec; 2004 Oct; 155(18):553-8. PubMed ID: 15559987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
